Original Research
Accepted on 23 Apr 2026
Neoadjuvant Camrelizumab in Combination with Chemotherapy Followed by Sequential Radical Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma: Postoperative Pathological Remission Characteristics and Influencing Factors
in Gastrointestinal Cancers: Gastric and Esophageal Cancers